Dermatology - Jul 17, 2024 - Omega-3 fatty acids found to significantly reduce acne in new study

Can't see this email? View it online

	Dermatology
	The latest dermatology news from News Medical

	Omega-3 fatty acids found to significantly reduce acne in new study Recent research highlights that omega-3 fatty acids significantly reduce acne severity. Supplementation and a Mediterranean diet improved skin condition in most study participants.

	Hidden threats in plant-based diets: Rising allergies to lesser-known legumes Researchers have identified emerging legume allergens like peas, lentils, and lupines, calling for more extensive studies and better diagnostics to manage increasing allergic reactions. The popularity of plant-based diets has brought new allergenic challenges to light.

			Scientists discover a molecular defect that promotes pathologic immune response in lupus Northwestern Medicine and Brigham and Women's Hospital scientists have discovered a molecular defect that promotes the pathologic immune response in systemic lupus erythematosus (known as lupus) and show that reversing this defect may potentially reverse the disease.

			How Aloe vera's medicinal properties make it essential in medicine, cosmetics, and food products Comprehensive review highlights Aloe vera's versatile biological activities and its potential applications in medicine and cosmetics while addressing its safety concerns.

			Archaeal, fungal, viral, as well as bacterial, functional makers for autism spectrum disorder in children Researchers investigated the associations between multikingdom gut microbiome components and functional markers with autism spectrum disorder through metagenomic sequencing of children's fecal samples.

	Chronic exposure to air pollutants may increase lupus risk, research shows New research published in Arthritis & Rheumatology indicates that chronic exposure to air pollutants may increase the risk of developing lupus, an autoimmune disease that affects multiple organs.

	40% of US cancer cases linked to lifestyle choices Nearly 40% of cancer cases and 44% of cancer deaths in 2019 were due to modifiable risk factors, with cigarette smoking as the leading cause. This study highlights the potential to significantly reduce cancer burden through lifestyle changes.

	FDA approved PDE4 inhibitor roflumilast for atopic dermatitis On July 9th, 2024, the U.S. FDA approved Arcutis Biotherapeutics' ZORYVE® (roflumilast) for treating atopic dermatitis (AD), the most common type of eczema affecting millions in the U.S. This once-daily, steroid-free cream could become a new standard of care for AD.

	Study: 40% of cancer cases in the U.S. attributable to modifiable risk factors A new study led by researchers at the American Cancer Society (ACS) finds four in 10 cancer cases and about one-half of all cancer deaths in adults 30 years old and older in the United States (or 713,340 cancer cases and 262,120 cancer deaths in 2019) could be attributed to modifiable risk factors, including cigarette smoking, excess body weight, alcohol consumption, physical inactivity, diet, and infections.

	Almirall's Ebglyss recommended by NICE for NHS atopic dermatitis patients Almirall S.A., a global biopharmaceutical company dedicated to medical dermatology, announced today that the National Institute for Health and Care Excellence (NICE) has recommended Ebglyss (lebrikizumab) for use in moderate to severe Atopic Dermatitis in the NHS England.

	Priority pathogens selected for wastewater surveillance during Paris 2024 Olympic and Paralympic Games The study by researchers from the French national public health institute aimed to identify priority pathogens that could be suitable for wastewater surveillance (WWS) during the Paris 2024 Olympic and Paralympic Games taking place from 26 July to 11 August and 28 August to 8 September, respectively.

	Global childhood immunization coverage: Stalled progress and growing gaps Global childhood immunization coverage stalled in 2023, leaving 2.7 million additional children un- and under-vaccinated compared to pre-pandemic levels in 2019, according to data published today by the World Health Organization (WHO) and UNICEF.

	Chronic Urticaria: Addressing unmet needs, emerging therapies, and advances in personalized treatment approaches Emerging personalized treatment approaches for chronic urticari.

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Unsubscribe or
Update Your Newsletter Subscriptions